Gray JE, Schenker M, Nahit Sendur MA, Leonova V, et al. The Phase 3 KEYLYNK-006 Study of Pembrolizumab plus Olaparib versus Pembrolizumab plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer. J Thorac Oncol 2024 Nov 7:S1556-0864(24)02435.
PMID: 39521434